A 15-Minute audio break: could guided imagery soothe heart patients?

NCT ID NCT07794358

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This trial tests whether guided imagery, a relaxation technique using audio recordings, can reduce anxiety and improve sleep and comfort in adults with acute coronary syndrome, such as a heart attack, who are in a cardiac intensive care unit. Participants will be randomly assigned to receive either routine care or routine care plus guided imagery sessions twice a day for two days. Researchers will compare changes in anxiety, sleep quality, and comfort between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Guided imagery, a relaxation technique using audio recordings that lead the listener through calming visualizations and breathing exercises
What this could lead to
If it works, guided imagery could become a simple, drug-free way to ease anxiety and improve sleep and comfort for people recovering from heart attacks in intensive care.
What could go wrong
This is a small, short-term trial, so the results may not apply to all heart patients. The effect may be modest, and the study does not measure long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Diagnosed with acute coronary syndrome, specifically ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI). * Admitted to and monitored in the cardiac intensive care unit. * Expected to remain in the cardiac intensive care unit for at least two nights and to be transferred to a ward or discharged after the two-day study period. * Clinically and hemodynamically stable, with no ongoing or increasing chest pain, significant respiratory distress, unstable vital signs, symptomatic serious arrhythmia, or need for urgent invasive intervention. * Conscious, oriented to person, place, and time, and able to communicate verbally. * Able to understand and speak Turkish. * No hearing impairment that would prevent listening to the guided imagery audio recording through headphones. * Sufficient cognitive ability to understand and respond to the study questionnaires. * Willing to participate and able to provide written informed consent. Exclusion Criteria: * Diagnosis of unstable angina pectoris. * Confusion, delirium, or any alteration in consciousness that interferes with communication. * Diagnosed dementia or cognitive impairment that prevents understanding study instructions. * Hearing loss that prevents following the audio instructions through headphones. * Inability to communicate verbally. * Clinical or hemodynamic instability, including ongoing chest pain, significant dyspnea, hemodynamic instability, symptomatic serious arrhythmia, or need for urgent intervention. * Receiving invasive mechanical ventilation or respiratory support that interferes with communication. * Receiving sedative treatment at a level that interferes with consciousness or communication. * Active psychosis, severe agitation, or an active psychiatric disorder that prevents following the guided imagery instructions. * Expected cardiac intensive care unit stay of less than two nights. * Refusal to participate or inability to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute coronary syndromes (ACS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.